SUPHA PHARMACHEM LIMITED
The ownership below is from 31 Dec 2025 — 2 quarters ago.
SUPHA PHARMACHEM LIMITED’s most recent shareholding filing is for the quarter ending 31 Dec 2025 (filed 9 Jan 2026). Read the figures as that filing, not as today’s position.
Who owns it
Promoters hold 1.1%, short of a majority — the public block is larger, led by other public holders at 90.9%.
Promoters hold 1.13% — too narrow to label as a column here; they’re named in the register below.
The public column also holds 6.23% Corporates and 1.70% Foreign, folded into the column above — each too small a slice of the public block to chart on its own.
Each block is that holder’s share of the company; counts are shareholder accounts, so one holder may hold several. As filed.
Little has moved since Mar 2024 — the promoter’s share shifted 0.02pp.
The public block is shown whole here — it’s a mix of funds, foreign investors, corporates and individuals, not one kind of holder. The register below names who’s in it; the split by category is on the treemap above.
Promoter’s share of the company at the first and latest quarters on record. Moves under 0.25pp show grey — at that size, rounding in the filing is as large as the move.
13 holders name themselves in this filing — promoters, institutions and public holders.
Ownership shown is promoter and public holding split by category, the named holders, and promoter pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
- 15 Apr 2025
A rights issue changed the number of shares outstanding, so prices and per-share figures on either side of this date aren’t directly comparable. It is why this page measures delivery and turnover only from the sessions after it — a comparison across it would mix two different share structures.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as SUPHA PHARMACHEM LIMITED having paid none.
Fundamentals and valuation — we hold neither. The government share of public holding — not broken out separately.
SUPHA PHARMACHEM LIMITED — a factual record of what it disclosed to the exchange and how its shares have traded, never advice. Every figure is dated to its filing; absence is stated, never shown as zero.